Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
ICR
Oct 16, 2024, 10:25 |
Immune Oncology
Immunotherapy for Breast Cancer: Types, Success Rate, Side Effects & More
Immunotherapy for breast cancer is gaining recognition as an innovative treatment for breast cancer, particularly…
Oct 15, 2024, 15:04 |
Blog
Naoto T Ueno: The impact of race and ethnicity on Inflammatory Breast Cancer
Naoto T Ueno, Executive Director of the Inflammatory Breast Cancer Research Program at the University…
Oct 15, 2024, 13:19 |
Insight
Highlights from the 2nd Annual Scientific Symposium at the James P. Allison Institute
The 2nd Annual Scientific Symposium at the James P. Allison Institute took place on October…
Oct 14, 2024, 18:42 |
Stories
Dikembe Mutombo: In Memory of Basketball Icon Who Died at 58 Battling Brain Cancer
Dikembe Mutombo, the towering basketball legend, has passed away at the age of 58 after…
Oct 14, 2024, 10:36 |
Insight
Transforming Cancer Research: New Optical Pooled Screening Facility at Danish Cancer Institute
Danish Cancer Institute shared a post on LinkedIn: “A new infrastructure facility at the Danish…
Oct 12, 2024, 18:32 |
Blog
Noubar Afeyan on celebrating Nobel Laureates Gary Ruvkun and Victor Ambros
Noubar Afeyan, Founder & CEO, Flagship Pioneering, shared a post on LinkedIn: "Heartfelt congratulations to…
Oct 12, 2024, 15:19 |
Insight
Nathan Pennell: Incredible effort from investigators all over the world on this paper
A recent paper by Ferdinandos Skoulidis et al. was published in Nature Journal. "CTLA4 blockade…
Oct 12, 2024, 10:21 |
Blog
Bishal Gyawali Was Honored with ASCO Fellowship for Outstanding Contributions to Oncology
The Ontario Institute for Cancer Research (OICR) is a leading research institute dedicated to advancing…
Oct 11, 2024, 19:32 |
Insight
Hung Trinh: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Hung Trinh shared a post on LinkedIn: “CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.…
Oct 11, 2024, 18:22 |
Blog
Imagine giving your immune system’s cancer-fighting cells a powerful energy boost to take on tumors - Parker Institute for Cancer Immunotherapy
Yan Leyfman shared a post by Parker Institute for Cancer Immunotherapy on LinkedIn, adding: "Pioneering work…
15
16
17
18
19
All:
805
Posts:
161 - 170
Why a Radiation Oncologist Isn’t Simply a Radiologist plus Medical Oncologist: Key Differences Explained
Dikembe Mutombo: In Memory of Basketball Icon Who Died at 58 Battling Brain Cancer
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 7
César Milstein - The Father of Modern Immunology
ESTRO: Everything You Need to Know About European Society for Radiotherapy and Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube